ORCHESTRA Delphi consensus: diagnostic and therapeutic management of Post-COVID-19 condition in vulnerable populations
| dc.rights.license | open | en_US |
| dc.contributor.author | GENTILOTTI, E. | |
| dc.contributor.author | CANZIANI, L. M. | |
| dc.contributor.author | CAPONCELLO, M. G. | |
| dc.contributor.author | AZZINI, A. M. | |
| dc.contributor.author | SAVOLDI, A. | |
| dc.contributor.author | DE NARDO, P. | |
| dc.contributor.author | PALACIOS-BAENA, Z. R. | |
| dc.contributor.author | TAZZA, B. | |
| dc.contributor.author | CAROCCIA, N. | |
| dc.contributor.author | MARCHETTI, G. | |
| dc.contributor.author | ANTINORI, A. | |
| dc.contributor.author | GIANNELLA, M. | |
| dc.contributor.author | RODRÍGUEZ-BAÑO, J. | |
| dc.contributor.author | TACCONELLI, E. | |
| dc.contributor.author | EXPERT TEAM, Expert Team Orchestra S. O. T. Panel | |
| dc.contributor.author | EXPERT TEAM, Orchestra P. W. H. Panel | |
| dc.contributor.author | EXPERT TEAM, Orchestra R. D. Panel | |
| dc.contributor.author | EXPERT TEAM, Orchestra H. M. Panel | |
| dc.contributor.author | GROUP, Orchestra Wp Working | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| hal.structure.identifier | Global Health in the Global South [GHiGS] | |
| dc.contributor.author | BONNET, Fabrice | |
| dc.date.accessioned | 2025-05-26T12:53:39Z | |
| dc.date.available | 2025-05-26T12:53:39Z | |
| dc.date.issued | 2025-04-17 | |
| dc.identifier.issn | 1469-0691 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/206717 | |
| dc.description.abstractEn | BACKGROUND: Post-COVID condition (PCC) remains poorly understood, especially in clinically vulnerable groups. Within the ORCHESTRA Project, we applied the Delphi approach to drive recommendations for the diagnosis, management, and prevention of PCC in people living with HIV (PWH) and patients affected by rheumatological diseases (RD) and haematological malignancies (HM). METHODS: Based on literature review, three areas of interest in PCC in PWH, HM, and RD were identified: 1) features and risk factors; 2) diagnosis and management; and 3) prevention. A three-round Delphi anonymous survey consisting of 15 questions was conducted including 69 experts. Consensus was measured by the 6-point Likert scale categorised into four tiers: strong disagreement, moderate disagreement, moderate agreement, and strong agreement. Statements were generated on questions achieving consensus. RESULTS: Eleven statements were generated: six on features and risk factors of PCC in clinically vulnerable populations, two on diagnosis and management, and three on prevention. Chronic fatigue was identified as the most frequent presentation of PCC in PWH and RD populations. A different case definition of PCC is required for RD population, as symptoms of PCC and autoimmune disorders may overlap. Risk factors for PCC include age>65, severity of COVID-19, and female sex; this latter is also associated with increased smell/taste impairment. A clinical assessment or a routine laboratory test performed three months after acute infection is not suggested to diagnose PCC in PWH. PWH and RD should be screened to exclude additional autoimmune disorders in case of chronic fatigue/arthralgia of new onset. Full-course vaccination and early treatment for COVID-19 should be promoted to prevent PCC, while corticosteroids during acute infection are not recommended. CONCLUSION: Diagnosis, management and prevention of PCC are still under discussion. This Delphi offers valuable insights on PCC in selected clinically vulnerable populations and suggests a tailored approach in vulnerable populations. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| dc.subject.en | Delphi | |
| dc.subject.en | HIV | |
| dc.subject.en | Haematological malignancies | |
| dc.subject.en | Long COVID | |
| dc.subject.en | Rheumatological diseases | |
| dc.title.en | ORCHESTRA Delphi consensus: diagnostic and therapeutic management of Post-COVID-19 condition in vulnerable populations | |
| dc.title.alternative | Clin Microbiol Infect | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.cmi.2025.04.009 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 40252805 | en_US |
| dc.description.sponsorshipEurope | Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA | en_US |
| bordeaux.journal | Clinical Microbiology and Infection | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | Coll_GHIGS | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Institut de Recherche pour le Développement | en_US |
| hal.identifier | hal-05085195 | |
| hal.version | 1 | |
| hal.date.transferred | 2025-05-26T12:53:44Z | |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical%20Microbiology%20and%20Infection&rft.date=2025-04-17&rft.eissn=1469-0691&rft.issn=1469-0691&rft.au=GENTILOTTI,%20E.&CANZIANI,%20L.%20M.&CAPONCELLO,%20M.%20G.&AZZINI,%20A.%20M.&SAVOLDI,%20A.&rft.genre=article |